Login to Your Account

U.S. Patent Disclosures

Thursday, December 29, 2011
• Prana Biotechnology Ltd., of Melbourne, Australia, received a notice of allowance for a patent, titled "Neurologically Active Compounds." It covers the composition of matter for selected 8-hydroxy quinazolinone compounds, including lead Parkinson's disease candidate PBT434.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription